Press Releases
Press Release filters
Sign up to receive updates from mdxhealth
Click the button below to fill in your contact information and receive updates from mdxhealth.
MDxHealth (R): MDxHealth Shareholder Transparency Declaration
Press release Regulated information 7 August 2018, 7.00 p.m. CET HERSTAL, BELGIUM and IRVINE, CA – August 7, 2018 – MDxHealth SA
MDxHealth: SelectMDx Study Demonstrates Cost-effectiveness in US Healthcare System
NEWS RELEASE REGULATED INFORMATION
MDxHealth (R): Medicare Establishes Final Positive Local Coverage Determination for Use of ConfirmMDx for Prostate Cancer
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;}
table.hugin { border-color:black;}
td.hugin { padding: 3px
MDxHealth (R): Presentation of New Data on MDxHealth’s Prostate and Bladder Cancer Products at AUA 2018 Annual Meeting
NEWS RELEASE Moderated posters and oral presentations feature clinical and health economic validations of SelectMDx, ConfirmMDx
MDxHealth Shareholder Transparency Declaration
Press releaseRegulated information6 April 2018, 5.45 p.m. CET MDxHealth Shareholder Transparency Declaration HERST
MDxHealth (R): MDxHealth Shareholder Transparency Declaration
Press release – Regulated information – 29 March 2018, 5.45 p.m. CET HERSTAL, BELGIUM and IRVINE, CA- March 29, 2018 – MDxHealt
MDxHealth (R): MDxHealth Successfully Completes a EUR 36 Million (USD 44 million)(1) Capital Increase
Press release – Regulated information – Inside information – 22 March 2018, 8.00 a.m.CET IRVINE, CA, and HERSTAL, BELGIUM – 22
MDxHealth (R): MDxHealth Launches Capital Increase
Press release – Regulated information – Inside information – 21 March 2018, 5:45 p.m. CET IRVINE, CA, and HERSTAL, BEL
MDxHealth (R): SelectMDx Liquid Biopsy Test for Prostate Cancer included in the 2018 European Association Urology Guidelines
NEWS RELEASE / REGULATED INFORMATION / INSIDE INFORMATION A significant milestone in MDxHealth’s strategy to increase adoption
MDxHealth (R): Develops Blood Test to Guide Precision-Treatment of Castration-Resistant Prostate Cancer Patients
NEWS RELEASE/REGULATED INFORMATION/INSIDE INFORMATION Study demonstrates test can add prognostic information on overall survival
MDxHealth: Shareholder Transparency Declaration
NEWS RELEASE REGULATED INFORMATION INSIDE INFORMATION MDxHealth: Shareholder Tr
MDxHealth (R) : MDxHealth annonce une baisse des prévisions
HERSTAL, BELGIQUE et IRVINE, CA, le 28 décembre 2017 – MDxHealth SA (Euronext : MDXH.BR), un leader mondial dans le diagnostic m
MDxhealth fait équipe avec la société pharmaceutique Ferrer pour distribuer SelectMDx en Espagne
Marché prometteur avec un nombre estimé de 300.000 hommes espagnols avec un taux de PSA élevé Le test urinaire molécul
Rapport d’activités des neuf premiers mois de MDxHealth
Le volume des tests pour les patients a augmenté de 43 % les neuf premiers mois Le volume des tests SelectMDx en Europe a augme
MDxHealth a conclu un contrat de distribution avec Unilabs pour le test de détection du cancer de la prostate SelectMDx
COMMUNIQUÉ DE PRESSE / INFORMATION REGLEMENTAIRE / INFORMATION PRIVILEGIEE IRVINE, CA, et HERSTAL, BELGIQUE – 07:00 CEST,
